Bidders circle Boots amid rumored US$10B offload
Sycamore Partners is reportedly considering selling UK pharmacy and beauty chain Boots for US$10 billion, one year after acquiring it. The move would replace the private equity firm’s previous plan to float Boots on the London Stock Exchange via an initial public offering (IPO). Sycamore originally took control of Boots in 2025 when it acquired the parent company, Walgreens Boots Alliance (WBA), in a US$23.7 billion takeover. After Sycamore broke WBA into five separate operating businesses, Boots now functions as a standalone asset that can be sold for a premium, and multiple bidders are lined up in agreement.This Technical Paper is brought to you by Sisterna.
Kacey Brides, marketing manager for North America at Givaudan, told us about PrimalHyal 300 at Suppliers’ Day. She explained how it differs from traditional hyaluronic acid, offering enhanced hydration, better penetration, and targeted benefits for sensitive or aging skin. She also shared the consumer trends and market demands that drove its development, such as post-procedure care.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines

The beauty of aging Jun 2026

Sun care reinventedJun 2026
Multimedia
Kacey Brides, marketing manager for North America at Givaudan, told us about PrimalHyal 300 at Suppliers’ Day. She explained how it differs from traditional hyaluronic acid, offering enhanced hydration, better penetration, and targeted benefits for sensitive or aging skin. She also shared the...




























